Drug treatment is a common option for metastatic kidney cancer. There are several types of treatment:
- Antiangiogenic therapy, commonly described as targeted therapy
- Chemotherapy, in combination with immunotherapy
These drugs influence the mechanisms that tumours use to grow. All decisions about the right therapy for you are taken after careful consideration of your general condition, your symptoms, and your prognosis. Further tests or scans are also used to see which treatment to select.
Generally, antiangiogenic therapy is recommended for kidney cancer. If you have a rare type of kidney cancer, your doctor may recommend chemotherapy treatment in combination with immunotherapy.